Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,022.95
(
0.80%
)
US TECH 100
25,535.20
(
1.56%
)
Dow Jones
48,463.72
(
-0.15%
)
Brent Oil
92.63
(
-0.03%
)
Bitcoin
75,048.21
(
0.30%
)
News Focus
News Focus
Post# of 517311
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

XenaLives

Send PM Follow Ignore
Followers 480
Posts 61845
Boards Moderated 15
Alias Born 09/20/2001

XenaLives

Member Level

Re: OFP post# 176569

Friday, 12/28/2018 5:35:34 PM

Friday, December 28, 2018 5:35:34 PM

Post# of 517311
Your argument as I understand it:

Ignore the clinical and preclinical studies showing AVXL 2-73 to be more effective than the S1 agonists already on the market and worry that all of those studies are meaningless....



In Peace, In War

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News